These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32921745)

  • 1. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
    Krishan K; Kanchan T
    Acta Biomed; 2020 Sep; 91(3):e2020023. PubMed ID: 32921745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
    Calligari P; Bobone S; Ricci G; Bocedi A
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and SARS-CoV-2: points to consider to face this new pandemic.
    Prieto Pozo AA; Salvador Sagüez FLD
    Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
    Ayaz S; Crea F
    Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
    [No Abstract]   [Full Text] [Related]  

  • 6. Singapore COVID-19 Pandemic Response as a Successful Model Framework for Low-Resource Health Care Settings in Africa?
    Kuguyo O; Kengne AP; Dandara C
    OMICS; 2020 Aug; 24(8):470-478. PubMed ID: 32552397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium for the 2019 novel coronavirus.
    Gómez-Bernal G
    Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
    [No Abstract]   [Full Text] [Related]  

  • 8. Type 1 interferons as a potential treatment against COVID-19.
    Sallard E; Lescure FX; Yazdanpanah Y; Mentre F; Peiffer-Smadja N
    Antiviral Res; 2020 Jun; 178():104791. PubMed ID: 32275914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
    Polansky H; Lori G
    J Evid Based Integr Med; 2020; 25():2515690X20932523. PubMed ID: 32551855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
    Ladoux A; Azoulay S; Dani C
    Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
    J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Coronavirus (COVID-19): A Global Pandemic.
    Al-Dadah O; Hing C
    Knee; 2020 Mar; 27(2):279. PubMed ID: 32354423
    [No Abstract]   [Full Text] [Related]  

  • 13. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 16. China Coronavirus Outbreak: All the Latest Updates.
    Scotti L; Scotti MT
    Curr Top Med Chem; 2020; 20(8):601-602. PubMed ID: 32133963
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.
    Abouleish M; El-Keblawy A; Mosa KA; Soliman SSM
    Curr Top Med Chem; 2020; 20(22):1958-1961. PubMed ID: 33040729
    [No Abstract]   [Full Text] [Related]  

  • 19. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.